眼科流感市場：依疾病類型、依給藥途徑、依藥物類別、依配銷通路、按地區

全球眼流感市場規模預計將從 2023 年的 45.4 億美元增至 2030 年的 77.7 億美元，預測期內CAGR為 8.0%。

圖 1. 2023 年眼流感全球市場佔有率（按地區分類）

眼流感，也稱為結膜炎，是一種常見的眼部感染疾病，影響全世界數百萬人。結膜炎的特徵是結膜發炎，結膜是覆蓋眼睛白色部分並排列在眼瞼內側的透明薄層。這種情況可能由多種因素引起，包括病毒和細菌感染、過敏和刺激物。

全球眼流感市場競爭激烈，多家主要企業佔據產業主導。市場的主要參與者包括諾華公司、艾爾建、Bausch Health、參天製藥、強生公司和 Alembic 製藥公司。這些公司提供多種眼部流感產品和治療方法，包括眼藥水、藥膏和內服藥物。

市場動態：

全球眼流感市場的成長是由多種因素推動的，例如眼部感染疾病盛行率的增加、對眼睛健康意識的提高以及醫療技術的進步。老年人口的增加以及過敏和刺激物發生率的增加也促進了市場的成長。

然而，也存在阻礙全球眼流感市場成長的因素。其中包括高昂的治療費用、發展中地區醫療機構的使用機會有限以及替代治療方法的可用性。他們也面臨嚴格的監管要求以及與某些藥物相關的副作用風險等挑戰。

儘管有這些挑戰，全球眼流感市場仍存在許多成長機會。新興經濟體對有效和安全治療方法的需求開拓、創新產品的開發以及醫療基礎設施的擴建預計將在不久的將來推動市場成長。

本研究的主要特點

• 本報告對全球眼流感市場進行了詳細分析，包括以2022年為基準年的預測期（2023-2030年）的市場規模和CAGR。
• 它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
• 它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
• 該報告的見解將使公司行銷人員和負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出資訊的決策。
• 全球眼流感市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球眼流感市場的各種策略矩陣，將促進相關人員的決策。

目錄

第1章 調查目的和假設

• 研究目標
• 假設
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 影響分析
• 主要亮點
• 監管場景
• 產品發布/核准
• PEST分析
• 波特的分析
• 併購場景

第4章 全球眼科流感市場－冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 全球眼科流感市場，依疾病類型，2018-2030

• 介紹
• 病毒性結膜炎
• 細菌性結膜炎
• 過敏性結膜炎
• 化學性結膜炎
• 其他

第6章 全球眼科流感市場，依給藥途徑，2018-2030

• 介紹
• 局部的
• 口服
• 靜脈

第7章 全球眼科流感市場，依藥物類別，2018-2030

• 介紹
• 抗生素
• 抗過敏
• 發炎藥
• 組合
• 其他

第8章 全球眼流感市場，依配銷通路分類，2018-2030 年

• 介紹
• 醫院藥房
• 零售藥房
• 線上藥房

第9章 全球眼流感市場，按地區，2018-2030

• 介紹
• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• 東南亞國協
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第10章 競爭形勢

• Novartis AG
• Allergan
• Bausch Health
• Santen Pharmaceutical
• Johnson & Johnson
• Alembic Pharmaceuticals
• Akorn Pharmaceuticals
• Alcon
• Pfizer
• Valeant Pharmaceuticals
• Merck & Co.
• Similasan Corporation
• Sun Pharmaceutical Industries
• Prestige Consumer Healthcare
• Lupin Pharmaceuticals
• Alembic Pharmaceuticals
• Aurolab
• Intas Pharmaceuticals
• Sun Pharma
• Cipla

第11章章節

• 調查方法
• 關於出版商

Global eye flu (conjunctivitis) market size is expected to reach US$ 7.77 billion by 2030, from US$ 4.54 billion in 2023, exhibiting a CAGR of 8.0% during the forecast period.

Figure 1. Global Eye Flu (Conjunctivitis) Market Share (%), By Region, 2023

Eye flu, also known as conjunctivitis, is a common eye infection that affects millions of people worldwide. It is characterized by inflammation of the conjunctiva, the thin, transparent layer that covers the white part of the eye and lines the inner surface of the eyelids. This condition can be caused by various factors including viral or bacterial infections, allergies, or irritants.

Global eye flu (conjunctivitis) market is highly competitive, with several key players dominating the industry. Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, and Alembic Pharmaceuticals are some of the leading companies in this market. These companies offer a wide range of products and treatments for eye flu including eye drops, ointments, and oral medications.

Market Dynamics:

Global eye flu (conjunctivitis) market growth is driven by several factors including the increasing prevalence of eye infections, growing awareness about eye health, and advancements in medical technology. Rising geriatric population and increasing incidence of allergies and irritants also contributes to the market growth.

However, there are certain restraints that may hinder growth of the global eye flu (conjunctivitis) market. These include the high cost of treatment, limited access to healthcare facilities in developing regions, and the availability of alternative treatments. The market faces challenges such as stringent regulatory requirements and the risk of adverse effects associated with certain medications.

Despite these challenges, the global eye flu (conjunctivitis) market presents numerous opportunities for growth. Increasing demand for effective and safe treatments, the development of innovative products, and the expansion of healthcare infrastructure in emerging economies are expected to drive the market growth in the near future.

Key Features of the Study:

• This report provides in-depth analysis of the global eye flu (conjunctivitis) market, including market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), with 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• Key companies covered as a part of this study include Novartis AG, Allergan, Bausch Health, Santen Pharmaceutical, Johnson & Johnson, Alembic Pharmaceuticals, Akorn Pharmaceuticals, Alcon, Pfizer, Valeant Pharmaceuticals, Merck & Co., Similasan Corporation, Sun Pharmaceutical Industries, Prestige Consumer Healthcare, Lupin Pharmaceuticals, Alembic Pharmaceuticals, Aurolab, Intas Pharmaceuticals, Sun Pharma, and Cipla
• Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global eye flu (conjunctivitis) market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye flu (conjunctivitis) market

Detailed Segmentation:

• By Disease Type
  • Viral Conjunctivitis
  • Bacterial Conjunctivitis
  • Allergic Conjunctivitis
  • Chemical Conjunctivitis
  • Others
• By Route of Administration
  • Topical
  • Oral
  • Intravenous
• By Drug Class
  • Antibiotics
  • Anti-allergy
  • Anti-inflammatories
  • Combination
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Novartis AG
  • Allergan
  • Bausch Health
  • Santen Pharmaceutical
  • Johnson & Johnson
  • Alembic Pharmaceuticals
  • Akorn Pharmaceuticals
  • Alcon
  • Pfizer
  • Valeant Pharmaceuticals
  • Merck & Co.
  • Similasan Corporation
  • Sun Pharmaceutical Industries
  • Prestige Consumer Healthcare
  • Lupin Pharmaceuticals
  • Alembic Pharmaceuticals
  • Aurolab
  • Intas Pharmaceuticals
  • Sun Pharma
  • Cipla

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Disease Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Drug Class
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Eye Flu (Conjunctivitis) Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Eye Flu (Conjunctivitis) Market, By Disease Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Viral Conjunctivitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Bacterial Conjunctivitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Allergic Conjunctivitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Chemical Conjunctivitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Eye Flu (Conjunctivitis) Market, By Route of Administration, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Topical
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Intravenous
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Eye Flu (Conjunctivitis) Market, By Drug Class, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Anti-allergy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Anti-inflammatories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Combination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Eye Flu (Conjunctivitis) Market, By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Eye Flu (Conjunctivitis) Market, By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
• South Africa
• North Africa
• Central Africa

10. Competitive Landscape

• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Allergan
• Bausch Health
• Santen Pharmaceutical
• Johnson & Johnson
• Alembic Pharmaceuticals
• Akorn Pharmaceuticals
• Alcon
• Pfizer
• Valeant Pharmaceuticals
• Merck & Co.
• Similasan Corporation
• Sun Pharmaceutical Industries
• Prestige Consumer Healthcare
• Lupin Pharmaceuticals
• Alembic Pharmaceuticals
• Aurolab
• Intas Pharmaceuticals
• Sun Pharma
• Cipla
• Analyst Views

11. Section

• Research Methodology
• About us